IL2RA and neoplasm: Tregs, characterized by CD4+/CD25+/FoxP3+ expression, can inhibit CD8+ T cell cytotoxicity by secreting immunosuppressive cytokines such as interleukin-10 (IL-10) and transforming growth factor-beta (TGF-β), thereby facilitating tumor immune evasion.